Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

Autor: Tara C. Jatlaoui, Grant T. Baldwin, Sarah Kabbani, Peter A. Briss, Emily V. Glidden, Emily N. Ussery, Mary Evans, Lisa J. Delaney, Pyone Cho, Lung Injury Response Clinical Task Force, Katrina F. Trivers, Lung Injury Response Epidemiology, Dale A. Rose, Kevin Chatham-Stephens, Katherine Roguski, Yunho Jang, Brian A. King, Christopher M. Jones, Surveillance Task Force, Matthew D. Ritchey
Rok vydání: 2019
Předmět:
Zdroj: Morbidity and Mortality Weekly Report
ISSN: 1545-861X
0149-2195
Popis: CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). As of November 13, 2019, 49 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands) have reported 2,172 EVALI cases to CDC, including 42 (1.9%) EVALI-associated deaths. To inform EVALI surveillance, including during the 2019-20 influenza season, case report information supplied by states for hospitalized and nonhospitalized patients with EVALI were analyzed using data collected as of November 5, 2019. Among 2,016 EVALI patients with available data on hospitalization status, 1,906 (95%) were hospitalized, and 110 (5%) were not hospitalized. Demographic characteristics of hospitalized and nonhospitalized patients were similar; most were male (68% of hospitalized versus 65% of nonhospitalized patients), and most were aged
Databáze: OpenAIRE